Irritable bowel syndrome, inflammatory bowel disease and TRPV1: How to disentangle the bundle

European Journal of Pain (United Kingdom)

Volumn 17, Issue 9, 2013, Pages 1263-1264

  Neri, Matteo ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; COLITIS, ULCERATIVE; COLON, SIGMOID; FEMALE; HUMANS; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; SOMATOSTATIN; SUBSTANCE P;

EID: 84888599622     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/j.1532-2149.2013.00345.x     Document Type: Note

References (12)

1. Akbar, A., Yiangou, Y., Facer, P., Brydon, W.G., Walters, J.R., Anand, P., Ghosh, S. (2010). Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. Gut 59, 767-774.
2. Akbar, A., Yiangou, Y., Facer, P., Walters, J.R., Anand, P., Ghosh, S. (2008). Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 57, 923-929.
3. Bortolotti, M., Porta, S. (2011). Effect of red pepper on symptoms of irritable bowel syndrome: Preliminary Study. Dig Dis Sci 56, 3288-3295.
4. Brock, C., Andresen, T., Frokjaer, J.B., Gale, J., Olesen, A.E., Arendt-Nielsen, L., Drewes, A.M. (2010). Central pain mechanisms following combined acid and capsaicin perfusion of the human oesophagus. Eur J Pain 14, 273-281.
5. Chadwick, V.S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., Wilson, I. (2002). Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122, 1778-1783.
6. Cremon, C., Gargano, L., Morselli-Labate AM Santini, D., Cogliandro, R.F., De Giorgio, R., Stanghellini, V., Corinaldesi, R., Barbara, G. (2009). Mucosal immune activation in irritable bowel syndrome: Genderdependence and association with digestive symptoms. Am J Gastroenterol 104, 392-400.
7. Gonlachanvit, S., Mahayosnond, A., Kullavanijaya, P. (2009). Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: Evidence for capsaicin-sensitive visceral nociception hypersensitivity. Neurogastroenterol Motil 21, 23-32.
8. Halpin, S.J., Ford, A.C. (2012). Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: Systematic review and meta-analysis. Am J Gastroenterol 107, 1474-1482.
9. Hamer, H.M., Jonkers, D.M., Vanhoutvin, S.A., Troost, F.J., Rijkers, G., de Bruine, A., Bast, A., Venema, K., Brummer, R.J. (2010). Effect of butyrate enemas on inflammation and antioxidant statusin the colonic mucosa of patients with ulcerative colitis in remission. Clin Nutr 29, 738-744.
10. Keszthelyi, D., Troost, F.J., Jonkers, D.M., Helyes, Z., Hamer, H.M., Ludidi, S., Vanhoutvin, S., Venema, K., Dekker, J., Szolcsányi, J., Masclee, A.A. (2013). Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: A role in pain symptom generation? Eur J Pain 17, 1299-1306.
11. Keszthelyi, D., Troost, F.J., Masclee, A.A. (2012). Irritable bowel syndrome: Methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 303, G141-G154.
12. Spiller, R., Garsed, K. (2009). Postinfectious irritable bowel syndrome. Gastroenterology 136, 1979-1988.